Loading...

BIVI BIOVIE INC Investments/Divestments 8-K Filing

BV N

BV

BIOVIE INC

(BIVI)

2023 8-K

Show Summary

Summary

Director Resignation

Annual Meeting Results

Public Offering

Nasdaq Compliance

Amendment for Reverse Stock...

Reverse Stock Split

Resignation of Director

Public Offering

Amendment Filing

Agreement for Stock Offering

Press Release and Investor ...

Annual Meeting of Stockholders

Clinical Trial Data Present...

Termination of Sales Agreement

Investor Presentation Update

Bylaws Amendment

Management Change

External Links:

BioVie Inc. released a press release and investor presentation disclosing top line data from its clinical trial of NE3107 in the treatment of Alzheimer's Disease.

AI Assistant

BIOVIE INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.